Karolinska Development
0.38 SEK
-1.19 %
Less than 1K followers
KDEV
NASDAQ Stockholm
Investment
Financials
Overview
Financials & Estimates
Ownership
Investor consensus
-1.19 %
-55.83 %
-60.32 %
-60.02 %
-60.65 %
-66.28 %
-77.92 %
-80.84 %
-98.94 %
Karolinska Development is an investment company focused on long-term equity investments in biotechnology and pharmaceutical companies. The company's goal is to develop promising medical innovations stemming from academic research at Karolinska Institutet and other universities in the Nordic region. The company's portfolio includes companies in sectors such as biotechnology and medical technology. Karolinska Development was founded in 2003 and is headquartered in Solna, Sweden.
Read moreMarket cap
101.28M SEK
Turnover
494.36K SEK
Revenue
1.84M
EBIT %
-497.83 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
13/2
2026
Annual report '25
30/4
2026
Interim report Q1'26
12/5
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
Karolinska Development’s portfolio company SVF Vaccines presents new preclinical data demonstrating extended effect of SVF-001 in chronic hepatitis B and D
Karolinska Development's portfolio company Modus Therapeutics initiates dosing in phase 2a study in patients with chronic kidney disease with anemia
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools